KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,216,708 | +1049.2% | 62,213 | +1063.1% | 0.25% | +1000.0% |
| Q2 2023 | $627,973 | +190.6% | 5,349 | +98.2% | 0.02% | +155.6% |
| Q1 2023 | $216,082 | -85.9% | 2,699 | -86.0% | 0.01% | -88.0% |
| Q4 2022 | $1,530,451 | +121.2% | 19,319 | +94.6% | 0.08% | +127.3% |
| Q3 2022 | $692,000 | -24.7% | 9,927 | -29.0% | 0.03% | -26.7% |
| Q2 2022 | $919,000 | -56.7% | 13,990 | -56.1% | 0.04% | -53.6% |
| Q1 2022 | $2,120,000 | +544.4% | 31,859 | +405.7% | 0.10% | +506.2% |
| Q3 2021 | $329,000 | -55.8% | 6,300 | -42.5% | 0.02% | -44.8% |
| Q2 2021 | $745,000 | -11.1% | 10,951 | +0.7% | 0.03% | +7.4% |
| Q1 2021 | $838,000 | -14.9% | 10,875 | -33.8% | 0.03% | -46.0% |
| Q4 2020 | $985,000 | -32.1% | 16,418 | -51.2% | 0.05% | -49.0% |
| Q3 2020 | $1,450,000 | -22.5% | 33,672 | -25.5% | 0.10% | -15.5% |
| Q2 2020 | $1,872,000 | – | 45,202 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |